Rafael Villalobos-Nieto
Neurodevelopmental Disabilities · Harlingen, TXNPI 1083638522
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 435 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 24.3% of the total. 2025 is the largest year on record at $2,126, 2.1 times the $996 reported in 2019.
Across 435 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$2K
- UCB, Inc.$1K
- Corium, LLC$626
- Jazz Pharmaceuticals Inc.$553
- Sunovion Pharmaceuticals Inc.$300
- Acadia Pharmaceuticals Inc$260
- plus $3K from 24 others
What the payments were for
- Food & beverage$7,671100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 95 | $1,868 |
| UCB, Inc. | 92 | $1,336 |
| Corium, LLC | 36 | $626 |
| Jazz Pharmaceuticals Inc. | 28 | $553 |
| Sunovion Pharmaceuticals Inc. | 25 | $300 |
| Acadia Pharmaceuticals Inc | 13 | $260 |
| Sarepta Therapeutics, Inc. | 12 | $254 |
| Collegium Pharmaceutical, Inc. | 22 | $245 |
| Otter Pharmaceuticals, LLC | 9 | $237 |
| SK Life Science, Inc. | 11 | $232 |
| PTC Therapeutics, Inc. | 10 | $225 |
| Catalyst Pharmaceuticals, Inc. | 11 | $210 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $200 |
| Upsher-smith Laboratories LLC | 10 | $188 |
| Sumitomo Pharma America, Inc. | 17 | $185 |
| Biogen | 1 | $120 |
| Livanova USA, Inc. | 5 | $96 |
| Azurity Pharmaceuticals, Inc. | 5 | $92 |
| Greenwich Biosciences, Inc. | 4 | $69 |
| Biocodex, Inc. | 2 | $62 |
| Springworks Therapeutics, Inc. | 3 | $60 |
| Shire North American Group Inc | 3 | $54 |
| Cycle Pharmaceuticals Inc | 2 | $40 |
| ITF Therapeutics LLC | 2 | $40 |
| Pyros Pharmaceuticals, Inc. | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Immedica Pharma US, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Zogenix Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPINRAZA$120
How this compares
Too few neurodevelopmental disabilities providers in Texasto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxcarbazepine | 12 | $1,328 |
| Clonidine Hcl | 27 | $46 |
Paid to pharmacies, not to this prescriber.
Other neurodevelopmental disabilities in Harlingen
- Rafael MimbelaDonna$10K
- Satish AgadiGalveston$8K
- Saeed KahkeshaniBaytown$3K
- Uloma LabrieDallas$2K
- Pamela LupoWebster$2K
- Linda NguyenDallas$526
- Vanessa Caress Mbanga TchakountePasadena$319
- Katrina Willie-MusomaMansfield$172
- Pauline FilipekHouston$168
- Sangeeta ElhenceFort Worth$100
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.